BIOXCEL THERAPEUT DL-,001 WKN: A2JF20 ISIN: US09075P1057 Kürzel: BTAI Forum: Aktien Thema: Hauptdiskussion

Stellt euch vor die Aktie wird irgendwann wieder auf 30 oder 50€ gehen 😬😬😬

Aber vielleicht hast du Recht . Ob nun knapp 60 k verlierst oder 80 k.

Du brauchst 2 €, dass wären wieviel Prozent Steigerung?

Ich habe den gleichen Fehler bei Quantum d Wave vor drei Monaten gemacht. Hätte ich nicht bei 60 cent verkauft wären es 40k. Und bei xrp gemacht.

Schreib das Geld ab und suche etwas gescheites.

Leider

Klingt nicht wirklich ermutigend.

BioXcel Therapeutics, Inc. (BTAI) is a pioneering biopharmaceutical company that is leveraging the power of AI to develop transformative medicines in neuroscience and immuno-oncology. The company's lead product, IGALMI TM, has been approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder, and BTAI is working to expand its commercial reach and pipeline. However, BTAI faces significant challenges, including its limited operating history, ongoing net losses, and substantial doubt about its ability to continue as a going concern. The company's reliance on third-party manufacturers and its relationship with BioXcel LLC also introduce additional risks. As BTAI navigates these obstacles and continues to advance its clinical programs, investors should closely monitor the company's progress, financial performance, and any updates regarding the development and commercialization of its product candidates. The company's ability to effectively execute its strategic reprioritization and secure additional funding will be critical to its long-term success.